Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

4.120 -0.170 (-3.96%)
Streaming Delayed Price Updated: 11:06 AM EDT, Sep 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 537,088
Open 4.290
Bid (Size) 4.100 (1)
Ask (Size) 4.120 (2)
Prev. Close 4.290
Today's Range 4.060 - 4.323
52wk Range 3.400 - 11.00
Shares Outstanding 14,508,063
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit

Performance

YTD
-48.0%
-48.0%
1 Month
+2.7%
+2.7%
3 Month
-34.6%
-34.6%
6 Month
-30.1%
-30.1%
1 Year
+5.4%
+5.4%

More News

Read More
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your
From Grabar Law Office
Via GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCY
From Pomerantz LLP
Via GlobeNewswire
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Levi & Korsinsky Notifies Shareholders of Unicycive Therapeutics, Inc. (UNCY) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Notifies Shareholders of Unicycive Therapeutics, Inc. (UNCY) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Unicycive Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Unicycive Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 - UNCY
From Faruqi & Faruqi LLP
Via GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCY
From Pomerantz LLP
Via GlobeNewswire
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Unicycive Therapeutics, Inc. (UNCY)
Via TheNewswire.com
Topics Fraud Lawsuit
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Unicycive Therapeutics, Inc. (UNCY)
Via NewMediaWire
Topics Fraud Lawsuit
Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (UNCY) to a Class Action Deadline on October 14, 2025
Via NewMediaWire
Topics Lawsuit
Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (UNCY) to a Class Action Deadline on October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Via TheNewswire.com
Topics Fraud Lawsuit
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?
Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?
Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?
The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market
What is the current price of Unicycive Therapeutics, Inc. - Common Stock?
The current price of Unicycive Therapeutics, Inc. - Common Stock is 4.120
When was Unicycive Therapeutics, Inc. - Common Stock last traded?
The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 09/11/25 11:06 AM ET
What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?
The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 59.77M
How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?
Unicycive Therapeutics, Inc. - Common Stock has 60M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.